Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

111

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Bipolar DisorderAnxiety Disorder

Interventions

DRUG

Risperidone

risperidone 0.5mg up to 4mg daily vs. placebo

Trial Locations (1)

University of Cincinnati Medical Center, Cincinnati